Selected research
Market Structure
Global Natural and Bio-Based Antimicrobials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Natural and Bio-Based Antimicrobials market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Natural and Bio-Based Antimicrobials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Natural and Bio-Based Antimicrobials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Natural and Bio-Based Antimicrobials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Natural and Bio-Based Antimicrobials is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Natural and Bio-Based Antimicrobials include Active Micro Technologies, Akema Fine Chemicals, Ashland, Chemipol, DuPont Nutrition & Biosciences, Evident Ingredients, Evonik, Minasolve and Sabinsa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines Natural and Bio-Based Antimicrobials output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of Natural and Bio-Based Antimicrobials by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global Natural and Bio-Based Antimicrobials market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Natural and Bio-Based Antimicrobials and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Natural and Bio-Based Antimicrobials sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Natural and Bio-Based Antimicrobials market size, projected growth trends, production technologies, key applications, and end-use industries.
Natural and Bio-Based Antimicrobials Segment by Company
Active Micro Technologies
Akema Fine Chemicals
Ashland
Chemipol
DuPont Nutrition & Biosciences
Evident Ingredients
Evonik
Minasolve
Sabinsa
SEPPIC
Troy Corporation
Vedeqsa
Natural and Bio-Based Antimicrobials Segment by Type
Plant Extracts
Plant Derivatives
Others
Natural and Bio-Based Antimicrobials Segment by Application
Cosmetic
Food
Medicine
Others
Natural and Bio-Based Antimicrobials Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural and Bio-Based Antimicrobials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Natural and Bio-Based Antimicrobials and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural and Bio-Based Antimicrobials.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Natural and Bio-Based Antimicrobials market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Natural and Bio-Based Antimicrobials industry.
Chapter 3: Detailed analysis of Natural and Bio-Based Antimicrobials market competition landscape. Including Natural and Bio-Based Antimicrobials manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Natural and Bio-Based Antimicrobials by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Natural and Bio-Based Antimicrobials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Plant Extracts
- Plant Derivatives
- Others
Applications
- Cosmetic
- Food
- Medicine
- Others
Companies covered
- Active Micro Technologies
- Akema Fine Chemicals
- Ashland
- Chemipol
- DuPont Nutrition & Biosciences
- Evident Ingredients
- Evonik
- Minasolve
- Sabinsa
- SEPPIC
- Troy Corporation
- Vedeqsa
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Natural and Bio-Based Antimicrobials Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global Natural and Bio-Based Antimicrobials Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global Natural and Bio-Based Antimicrobials Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global Natural and Bio-Based Antimicrobials Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global Natural and Bio-Based Antimicrobials Market Dynamics
- 2.1 Natural and Bio-Based Antimicrobials Industry Trends
- 2.2 Natural and Bio-Based Antimicrobials Industry Drivers
- 2.3 Natural and Bio-Based Antimicrobials Industry Opportunities and Challenges
- 2.4 Natural and Bio-Based Antimicrobials Industry Restraints
3 Natural and Bio-Based Antimicrobials Market by Manufacturers
- 3.1 Global Natural and Bio-Based Antimicrobials Production Value by Manufacturers (2021-2026)
- 3.2 Global Natural and Bio-Based Antimicrobials Production by Manufacturers (2021-2026)
- 3.3 Global Natural and Bio-Based Antimicrobials Average Price by Manufacturers (2021-2026)
- 3.4 Global Natural and Bio-Based Antimicrobials Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Natural and Bio-Based Antimicrobials Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Natural and Bio-Based Antimicrobials Manufacturers, Product Type & Application
- 3.7 Global Natural and Bio-Based Antimicrobials Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Natural and Bio-Based Antimicrobials Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Natural and Bio-Based Antimicrobials Players Market Share by Production Value in 2025
- 3.8.3 2025 Natural and Bio-Based Antimicrobials Tier 1, Tier 2, and Tier 3
4 Natural and Bio-Based Antimicrobials Market by Type
- 4.1 Natural and Bio-Based Antimicrobials Type Introduction
- 4.1.1 Plant Extracts
- 4.1.2 Plant Derivatives
- 4.1.3 Others
- 4.2 Global Natural and Bio-Based Antimicrobials Production by Type
- 4.2.1 Global Natural and Bio-Based Antimicrobials Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Natural and Bio-Based Antimicrobials Production by Type (2021-2032)
- 4.2.3 Global Natural and Bio-Based Antimicrobials Production Market Share by Type (2021-2032)
- 4.3 Global Natural and Bio-Based Antimicrobials Production Value by Type
- 4.3.1 Global Natural and Bio-Based Antimicrobials Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Natural and Bio-Based Antimicrobials Production Value by Type (2021-2032)
- 4.3.3 Global Natural and Bio-Based Antimicrobials Production Value Market Share by Type (2021-2032)
5 Natural and Bio-Based Antimicrobials Market by Application
- 5.1 Natural and Bio-Based Antimicrobials Application Introduction
- 5.1.1 Cosmetic
- 5.1.2 Food
- 5.1.3 Medicine
- 5.1.4 Others
- 5.2 Global Natural and Bio-Based Antimicrobials Production by Application
- 5.2.1 Global Natural and Bio-Based Antimicrobials Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Natural and Bio-Based Antimicrobials Production by Application (2021-2032)
- 5.2.3 Global Natural and Bio-Based Antimicrobials Production Market Share by Application (2021-2032)
- 5.3 Global Natural and Bio-Based Antimicrobials Production Value by Application
- 5.3.1 Global Natural and Bio-Based Antimicrobials Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Natural and Bio-Based Antimicrobials Production Value by Application (2021-2032)
- 5.3.3 Global Natural and Bio-Based Antimicrobials Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Active Micro Technologies
- 6.1.1 Active Micro Technologies Company Information
- 6.1.2 Active Micro Technologies Business Overview
- 6.1.3 Active Micro Technologies Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.1.4 Active Micro Technologies Natural and Bio-Based Antimicrobials Product Portfolio
- 6.1.5 Active Micro Technologies Recent Developments
- 6.2 Akema Fine Chemicals
- 6.2.1 Akema Fine Chemicals Company Information
- 6.2.2 Akema Fine Chemicals Business Overview
- 6.2.3 Akema Fine Chemicals Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.2.4 Akema Fine Chemicals Natural and Bio-Based Antimicrobials Product Portfolio
- 6.2.5 Akema Fine Chemicals Recent Developments
- 6.3 Ashland
- 6.3.1 Ashland Company Information
- 6.3.2 Ashland Business Overview
- 6.3.3 Ashland Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.3.4 Ashland Natural and Bio-Based Antimicrobials Product Portfolio
- 6.3.5 Ashland Recent Developments
- 6.4 Chemipol
- 6.4.1 Chemipol Company Information
- 6.4.2 Chemipol Business Overview
- 6.4.3 Chemipol Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.4.4 Chemipol Natural and Bio-Based Antimicrobials Product Portfolio
- 6.4.5 Chemipol Recent Developments
- 6.5 DuPont Nutrition & Biosciences
- 6.5.1 DuPont Nutrition & Biosciences Company Information
- 6.5.2 DuPont Nutrition & Biosciences Business Overview
- 6.5.3 DuPont Nutrition & Biosciences Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.5.4 DuPont Nutrition & Biosciences Natural and Bio-Based Antimicrobials Product Portfolio
- 6.5.5 DuPont Nutrition & Biosciences Recent Developments
- 6.6 Evident Ingredients
- 6.6.1 Evident Ingredients Company Information
- 6.6.2 Evident Ingredients Business Overview
- 6.6.3 Evident Ingredients Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.6.4 Evident Ingredients Natural and Bio-Based Antimicrobials Product Portfolio
- 6.6.5 Evident Ingredients Recent Developments
- 6.7 Evonik
- 6.7.1 Evonik Company Information
- 6.7.2 Evonik Business Overview
- 6.7.3 Evonik Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.7.4 Evonik Natural and Bio-Based Antimicrobials Product Portfolio
- 6.7.5 Evonik Recent Developments
- 6.8 Minasolve
- 6.8.1 Minasolve Company Information
- 6.8.2 Minasolve Business Overview
- 6.8.3 Minasolve Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.8.4 Minasolve Natural and Bio-Based Antimicrobials Product Portfolio
- 6.8.5 Minasolve Recent Developments
- 6.9 Sabinsa
- 6.9.1 Sabinsa Company Information
- 6.9.2 Sabinsa Business Overview
- 6.9.3 Sabinsa Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.9.4 Sabinsa Natural and Bio-Based Antimicrobials Product Portfolio
- 6.9.5 Sabinsa Recent Developments
- 6.10 SEPPIC
- 6.10.1 SEPPIC Company Information
- 6.10.2 SEPPIC Business Overview
- 6.10.3 SEPPIC Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.10.4 SEPPIC Natural and Bio-Based Antimicrobials Product Portfolio
- 6.10.5 SEPPIC Recent Developments
- 6.11 Troy Corporation
- 6.11.1 Troy Corporation Company Information
- 6.11.2 Troy Corporation Business Overview
- 6.11.3 Troy Corporation Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.11.4 Troy Corporation Natural and Bio-Based Antimicrobials Product Portfolio
- 6.11.5 Troy Corporation Recent Developments
- 6.12 Vedeqsa
- 6.12.1 Vedeqsa Company Information
- 6.12.2 Vedeqsa Business Overview
- 6.12.3 Vedeqsa Natural and Bio-Based Antimicrobials Production, Value and Gross Margin (2021-2026)
- 6.12.4 Vedeqsa Natural and Bio-Based Antimicrobials Product Portfolio
- 6.12.5 Vedeqsa Recent Developments
7 Global Natural and Bio-Based Antimicrobials Production by Region
- 7.1 Global Natural and Bio-Based Antimicrobials Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global Natural and Bio-Based Antimicrobials Production by Region (2021-2032)
- 7.2.1 Global Natural and Bio-Based Antimicrobials Production by Region (2021-2026)
- 7.2.2 Global Natural and Bio-Based Antimicrobials Production Forecast by Region (2027-2032)
- 7.3 Global Natural and Bio-Based Antimicrobials Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global Natural and Bio-Based Antimicrobials Production Value by Region (2021-2032)
- 7.4.1 Global Natural and Bio-Based Antimicrobials Production Value by Region (2021-2026)
- 7.4.2 Global Natural and Bio-Based Antimicrobials Production Value by Region (2027-2032)
- 7.5 Global Natural and Bio-Based Antimicrobials Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America Natural and Bio-Based Antimicrobials Production Value (2021-2032)
- 7.6.2 Europe Natural and Bio-Based Antimicrobials Production Value (2021-2032)
- 7.6.3 Asia-Pacific Natural and Bio-Based Antimicrobials Production Value (2021-2032)
- 7.6.4 South America Natural and Bio-Based Antimicrobials Production Value (2021-2032)
- 7.6.5 Middle East & Africa Natural and Bio-Based Antimicrobials Production Value (2021-2032)
8 Global Natural and Bio-Based Antimicrobials Consumption by Region
- 8.1 Global Natural and Bio-Based Antimicrobials Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global Natural and Bio-Based Antimicrobials Consumption by Region (2021-2032)
- 8.2.1 Global Natural and Bio-Based Antimicrobials Consumption by Region (2021-2026)
- 8.2.2 Global Natural and Bio-Based Antimicrobials Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America Natural and Bio-Based Antimicrobials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America Natural and Bio-Based Antimicrobials Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe Natural and Bio-Based Antimicrobials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe Natural and Bio-Based Antimicrobials Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Natural and Bio-Based Antimicrobials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific Natural and Bio-Based Antimicrobials Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America Natural and Bio-Based Antimicrobials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America Natural and Bio-Based Antimicrobials Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa Natural and Bio-Based Antimicrobials Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa Natural and Bio-Based Antimicrobials Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 Natural and Bio-Based Antimicrobials Value Chain Analysis
- 9.1.1 Natural and Bio-Based Antimicrobials Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Natural and Bio-Based Antimicrobials Production Mode & Process
- 9.2 Natural and Bio-Based Antimicrobials Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Natural and Bio-Based Antimicrobials Distributors
- 9.2.3 Natural and Bio-Based Antimicrobials Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst